XLS Medical Fat Binder is a special range of XLS,
contains Litramine , a unique substance based on vegetable fibres and enriched with the fatsoluble vitamins A, D and E.
XLS Medical Fat Binder with vitamins binds up to 27 % of dietary fats in the stomach by absorbing the fat molecules to form a fat-fibre complex. It ensures optimum fat binding in the first phase and, in the second phase, fat-soluble vitamins are released into the body to ensure optimum vitamin absorption.
XLS Medical Fat Binder helps you to lose up to 3x more weight than with a diet alone.
XLS Medical Fat Binder is for everyone with overweight or obesity. XLS Medical Fat Binder has a unique triple action effect:
-Binds up to 28% of fat intake
-Reduces appetite and sweet cravings
-Improves gastrointestinal transit XLS Medical Fat Binder is also good for your health and has a proven effect on:
-Metabolic syndrome reductionThe excellent fat absorption capacity of XLS Medical Fat Binder has been proven in numerous clinical studies:
-XLS Medical Fat Binder reduces fat absorption by up to 28% with no undesirable side effects
-XLS Medical Fat Binder reduces LDL-Cholesterol (bad cholesterol) by 10% within 14 days4
-XLS Medical Fat Binder reduces metabolic syndrome by 39% within 42 days4
-XLS Medical Fat Binder has a proven effect on the feeling of fullness: 80% of patients reported a moderate to high increase in fullness2 XLS Medical Fat Binder helps you to lose up to 3X more weight than with a diet alone.
All these results are achieved with no undesirable side effects
1. In vivo Pilot Clinical Study, placebo-controlled, double-blind clinical study, conducted by CERN, (Centre d’Enseignement et de Recherche en Nutrition) in France, 2003.
2. In vivo, 2-armed, randomised, placebo-controlled, double-blind study, conducted in Germany, 2009.
3 Double-blind, randomized, placebo-controlled, crossover clinical investigation to evaluate the effect of Litramine on fecal fat excretion in healthy subjects, Germany, 2012.
4 Linarès E. et al., The effect of NeOpuntia on Blood Lipid Parameters – Risk Factors for the Metabolic Syndrome (Syndrome X), Advances in Therapy, September/October 2007.